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Endoscopic mucosal resection (EMR) is a 
technique used for the staging and treatment of 
superficial neoplasms of the gastrointestinal tract 
(GIT). The technique was first developed in Japan 
for the treatment of early gastric cancers and then 
disseminated throughout the world for various 
indications, including sessile colonic neoplasms. 
This method is used to provide accurate histological 
staging of superficial gastrointestinal neoplasms and 
provides a minimally invasive technique for their 
removal.
There are several variations of EMR that are 
currently in use, including injection-assisted, cap-
assisted, and ligation-assisted techniques. All of then 
adhere to the basic principles of identification and 
demarcation of the lesion, submucosal injection to 
lift the lesion, and endoscopic snare resection. Due 
to its overall safety and efficacy in appropriately 
selected patient populations, EMR has become 
firmly integrated in the diagnostic and treatment 
algorithms of superficial GIT malignancies.
EMR may be considered for definitive therapy 
of superficial premalignant and well-differentiated to 
moderately-differentiated GIT malignant lesions in 
the absence of lymph node or distant metastases (T1m 
N0M0). It also plays an integral role in the staging 
algorithm of early GIT cancers by providing a larger 
resection specimen than standard forceps biopsy, 
allowing for accurate T-staging and establishing the 
presence of lymphovascular involvement. 
EMR is commonly used for the resection 
of laterally spreading benign lesions or early 
adenocarcinoma of the colon. The ‘lift-and-cut’ 
technique is most commonly used. Appropriate 
indications include lesions that are: i) well-
differentiated or moderately-differentiated tumours 
confined to the mucosa, ii) type o-IIa less than 2 cm, 
iii) type o-IIb less than 1 cm, or iv) type o-IIc less 
than 1 cm in size. 
Additional indications include either the 
patients who refuse surgical intervention, or those 
in whom significant comorbidities are prohibitive. 
Successful removal of larger lesions is well-
documented. However, it is associated with higher 
recurrence rates, highlighting the need for intensive 
post-EMR surveillance. 
EMR should be performed by experienced 
operators in a center of expertise. Appropriate 
adjuncts to treatment should be readily available 
in the operating room. Additionally, interventional 
radiology and surgical back-up should be available in 
the event of uncontrolled hemorrhage or perforation.
Long-term outcomes following EMR of flat 
premalignant lesions and early colorectal cancer 
vary widely in the incidence of recurrence ranging 
from 0% to 40%. Variations in technical expertise 
and heterogeneity in lesions included for treatment 
are partially responsible for this wide disparity. 
overall, however, most recurrences are amenable 
to repeat endoscopic treatment during surveillance 
colonoscopy. En bloc resection and lesion size of 2 
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cm or less are associated with lower local recurrence 
rates.
Due to risk of remnant tissue or local recurrence, 
close surveillance is generally recommended. Repeat 
colonoscopy may be performed within at least 4-6 
weeks to ensure that the whole dysplastic tissue has 
been resected or ablated. Follow-up colonoscopy 
with surveillance biopsies is most often performed 
3-6 months after EMR, and subsequent surveillance 
is adjusted based on the status of recurrence.
In Jordan, there is already certain experience 
with the endoscopic submucosal resection. Several 
experts and authors of the study after a training period 
in such procedure in Japan started EMR in 2004 
for superficial gastric and colonic mucosal masses. 
This prospective clinical trial will be performed 
until 2013 at Al Bashir gastrointestinal endoscopic 
unit, Amman, Jordan. It covered a total of 292 
cases, 135 with gastric and 157 with colonic lesions. 
Colonic lesions that underwent EMR presented as 23 
carcinomas in situ, 40 polyps with severe dysplasia, 
57 with moderate to severe dysplasia, 24 with mild 
dysplasia and 14 inflammatory (hyperplastic) polyps. 
There were no immediate or late complications, 
no recurrence in any examined subjects at all.
The procedure was well-tolerated by the 
patients. Minimal mild abdominal pain occurred 
after the procedure in some patients, and minor 
bleeding occurred during the procedure in other 
ones only. No perforations or major bleeding events 
were recorded.
All the patients with carcinoma in situ and 
moderate to severe dysplasia did not show any 
recurrences after follow-up colonoscopies.
This procedure is considered safe and efficient 
in selected patients with superficial gastrointestinal 
neoplasms when performed by experienced operators 
in a center of expertise.
